comparemela.com

Latest Breaking News On - Wealth management partners - Page 1 : comparemela.com

Barometer Capital Management Inc. Sells 660 Shares of ServiceNow, Inc. (NYSE:NOW)

Barometer Capital Management Inc. reduced its position in shares of ServiceNow, Inc. (NYSE:NOW – Free Report) by 21.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,433 shares of the information technology services provider’s stock after selling 660 shares during the period. […]

Barometer Capital Management Inc. Sells 660 Shares of ServiceNow, Inc. (NYSE:NOW)

Barometer Capital Management Inc. reduced its position in shares of ServiceNow, Inc. (NYSE:NOW – Free Report) by 21.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,433 shares of the information technology services provider’s stock after selling 660 shares during the period. […]

Waterloo Capital L.P. Buys 3,623 Shares of JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI)

Waterloo Capital L.P. increased its stake in shares of JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI – Free Report) by 19.3% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 22,398 shares of the company’s stock after acquiring an additional 3,623 shares during the quarter. Waterloo Capital L.P.’s holdings in JPMorgan Equity Premium Income ETF […]

Summit Therapeutics (NASDAQ:SMMT) Trading 8.1% Higher

Summit Therapeutics Inc. (NASDAQ:SMMT – Get Free Report)’s share price traded up 8.1% during mid-day trading on Wednesday . The company traded as high as $7.92 and last traded at $7.90. 2,589,140 shares traded hands during mid-day trading, a decline of 19% from the average session volume of 3,208,273 shares. The stock had previously closed […]

StockNews.com Downgrades Fortress Biotech (NASDAQ:FBIO) to Sell

Fortress Biotech (NASDAQ:FBIO – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Monday. Several other research firms have also recently weighed in on FBIO. Alliance Global Partners initiated coverage on shares of Fortress Biotech in a research report […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.